Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug reimbursement
Pharma
AZ's Enhertu, Akeso's bispecifics win reimbursement in China
While AZ/Daiichi's Enhertu and Roche's Polivy earned national reimbursement in China, Gilead's Trodelvy and Pfizer's Besponsa didn't.
Angus Liu
Dec 4, 2024 12:52pm
Eisai, Biogen's Leqembi nabs UK nod but not reimbursement
Aug 22, 2024 9:23am
IRA negotiations slash prices for blockbuster drugs by up to 79%
Aug 15, 2024 9:00am
BioMarin downsizes gene therapy efforts to focus on 3 markets
Aug 6, 2024 10:34am
Vertex inks long-term access deal for CF meds in England
Jun 21, 2024 11:31am
Madrigal builds launch infrastructure for MASH drug Rezdiffra
May 7, 2024 11:56am
